Strumento inattivo

Altre lingue VIVUS, Inc.

Azioni

VVUSQ

US9285513084

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

VIVUS LLC Announces It Will Provide Telehealth to Patients Through an Enhanced 'Engage' Program in Collaboration with UpScriptHealth	22/04
VIVUS LLC Announces Positive Topline Data from a Post-Marketing Study to Evaluate the Effect of QSYMIA	28/11
VIVUS, Inc. Promotes Santosh T. Varghese to President VIVUS Global Pharmaceutical Development	10/01/23
FDA Approves VIVUS LLC's QSYMIA® for the Treatment of Obesity in Adolescents Ages 12-17	20/07/22
VIVUS : Receives Court Approval of Joint Chapter 11 Plan of Reorganization	14/12/20
VIVUS, Inc. Emerged from Bankruptcy	11/12/20
Revised Second Amended Reorganization Plan & Disclosure Statement Approved for VIVUS, Inc.	10/12/20
First Motion for Exclusivity Period Extension Approved For VIVUS, Inc.	17/11/20
VIVUS : Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Date	16/11/20
VIVUS INC : Other Events, Financial Statements and Exhibits (form 8-K)	16/11/20
Second Amended Joint Pre-Packaged Reorganization Plan Filed by VIVUS, Inc.	10/11/20
First Motion for Exclusivity Period Extension Filed by VIVUS, Inc.	04/11/20
Motion for Asset Sale Filed by VIVUS, Inc.	20/10/20
First Amended Joint Pre-Packaged Reorganization Plan Filed by VIVUS, Inc.	18/08/20
VIVUS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure (form 8-K)	13/07/20
VIVUS, Inc.(NasdaqGS:VVUS) dropped from S&P TMI Index	10/07/20
Motion for Joint Administration Approved for VIVUS, Inc.	10/07/20
Combined Hearing for Disclosure Statement and Plan Approved for VIVUS, Inc.	10/07/20
Health Care Flat As Growth Investors Seek Out Tech -- Health Care Roundup	08/07/20
VIVUS INC : Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	07/07/20

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue VIVUS, Inc.

Azioni

VVUSQ

US9285513084

Altre lingue

Filtri